This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, including antipsychotic and antidepressant medications. Its structural features, particularly the piperazine moiety, enhance binding affinity to specific receptors in the brain, making it valuable for designing therapeutic agents. Additionally, it is employed in research settings for exploring novel compounds with potential pharmacological activities, particularly in the field of neuropharmacology.